Literature DB >> 25421156

Role of genetic and non-genetic factors in the etiology of Graves' disease.

M Marinò1,2, F Latrofa3,4, F Menconi3,4, L Chiovato5, P Vitti3,4.   

Abstract

In spite of the advancements in understanding the pathogenic mechanisms of Graves' disease (GD), its ultimate cause remains elusive. The majority of investigators agree that GD is likely a multifactorial disease, due to a complex interplay of genetic and non-genetic factors that lead to the loss of immune tolerance to thyroid antigens and to the initiation of a sustained autoimmune reaction. Twin and family studies support a role of genetic factors, among which the HLA complex, CD40, CTLA-4, PTPN22, FCRL3, thyroglobulin, and the TSH receptor may be involved. Among non-genetic factors, iodine, infections, psychological stress, gender, smoking, thyroid damage, vitamin D, selenium, immune modulating agents, and periods of immune reconstitution may contribute the development of the diseases. Here we review in detail the respective role of genetic and non-genetic factors in the etiology of GD, taking advantage of the great bulk of data generated especially over the past 30 years.

Entities:  

Keywords:  Autoimmunity; Environment; Genetics; Graves’ disease; Hyperthyroidism

Mesh:

Substances:

Year:  2014        PMID: 25421156     DOI: 10.1007/s40618-014-0214-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  135 in total

Review 1.  Genetic developments in autoimmune thyroid disease: an evolutionary process.

Authors:  Abigail A Zeitlin; Matthew J Simmonds; Stephen C L Gough
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-13       Impact factor: 3.478

2.  HLA class II associations in African-American female patients with Graves' disease.

Authors:  T Yanagawa; L J DeGroot
Journal:  Thyroid       Date:  1996-02       Impact factor: 6.568

3.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

Review 4.  An update on the medical treatment of Graves' hyperthyroidism.

Authors:  Michele Marinò; Francesco Latrofa; Francesca Menconi; Luca Chiovato; Paolo Vitti
Journal:  J Endocrinol Invest       Date:  2014-09-04       Impact factor: 4.256

5.  Retrovirus-like sequences in Graves' disease: implications for human autoimmunity.

Authors:  A Ciampolillo; V Marini; R Mirakian; M Buscema; T Schulz; R Pujol-Borrell; G F Bottazzo
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

Review 6.  Expression and biological significance of human endogenous retroviral sequences.

Authors:  C Leib-Mösch; M Bachmann; R Brack-Werner; T Werner; V Erfle; R Hehlmann
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

7.  Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis.

Authors:  H B Burch; E V Nagy; Y G Lukes; W Y Cai; L Wartofsky; K D Burman
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

Review 8.  Diagnosis and classification of Graves' disease.

Authors:  Francesca Menconi; Claudio Marcocci; Michele Marinò
Journal:  Autoimmun Rev       Date:  2014-01-12       Impact factor: 9.754

Review 9.  Gender and autoimmunity.

Authors:  Gisele Zandman-Goddard; Elena Peeva; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2006-11-13       Impact factor: 9.754

10.  New genetic insights from autoimmune thyroid disease.

Authors:  Terry F Davies; Rauf Latif; Xiaoming Yin
Journal:  J Thyroid Res       Date:  2012-02-28
View more
  42 in total

1.  Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.

Authors:  H Korkmaz; S Tabur; M Ozkaya; E Oguz; N Aksoy; E Akarsu
Journal:  J Endocrinol Invest       Date:  2015-04-22       Impact factor: 4.256

Review 2.  Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.

Authors:  Barbara Altieri; Giovanna Muscogiuri; Luigi Barrea; Chantal Mathieu; Carla V Vallone; Luca Mascitelli; Giorgia Bizzaro; Vincenzo M Altieri; Giacomo Tirabassi; Giancarlo Balercia; Silvia Savastano; Nicola Bizzaro; Cristina L Ronchi; Annamaria Colao; Alfredo Pontecorvi; Silvia Della Casa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

3.  Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study.

Authors:  G Lanzolla; E Sabini; M A Profilo; B Mazzi; A Sframeli; R Rocchi; F Menconi; M Leo; M Nardi; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2018-06-19       Impact factor: 4.256

4.  Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Authors:  M Leo; L Bartalena; G Rotondo Dottore; E Piantanida; P Premoli; I Ionni; M Di Cera; E Masiello; L Sassi; M L Tanda; F Latrofa; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-10-12       Impact factor: 4.256

5.  CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation.

Authors:  Hanna J Lee; Angela Lombardi; Mihaela Stefan; Cheuk Wun Li; William B Inabnet; Randall P Owen; Erlinda Concepcion; Yaron Tomer
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 6.  The thyroid, the eyes and the gut: a possible connection.

Authors:  D Covelli; M Ludgate
Journal:  J Endocrinol Invest       Date:  2017-01-07       Impact factor: 4.256

7.  Safety of total thyroid ablation in patients with Graves' orbitopathy.

Authors:  M Moleti; G Sturniolo; F Vermiglio
Journal:  J Endocrinol Invest       Date:  2016-05-20       Impact factor: 4.256

8.  Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.

Authors:  M Leo; F Maggi; G R Dottore; G Casini; P Mazzetti; M Pistello; S Sellari-Franceschini; M Nardi; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-12-16       Impact factor: 4.256

9.  The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Authors:  L Bartalena; E Masiello; F Magri; G Veronesi; E Bianconi; F Zerbini; M Gaiti; E Spreafico; D Gallo; P Premoli; E Piantanida; M L Tanda; M Ferrario; P Vitti; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256

10.  Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.

Authors:  Q Yuan; Y Zhao; X Zhu; X Liu
Journal:  J Endocrinol Invest       Date:  2016-11-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.